Showing results (151-160 of 401) with videos related to

Sort By:
Pageof 41
Cytotherapy|May 15, 2018
Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphomaLisa-Marie Pfeffermann, Verena Pfirrmann, Sabine Huenecke, et al.
Frontiers in Immunology|December 31, 2024
Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantationSarah Kayser, Emilia Salzmann-Manrique, Hubert Serve, et al.
Cytotherapy|September 13, 2011
Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive propertiesZyrafete Kuçi, Selim Kuçi, Susanne Zircher, et al.
Annals of Hematology|August 13, 2014
Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantationMichaela Döring, Karin Melanie Rohrer, Annika Erbacher, et al.
Leukemia|December 16, 2024
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemiaTommaso Balestra, Lisa M Niswander, Asen Bagashev, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cellsSteven A Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, et al.
Journal of Immunological Methods|April 9, 2008
Enumeration of functionally active anti-Aspergillus T-cells in human peripheral bloodOlaf Beck, Ulrike Koehl, Lars Tramsen, et al.
European Journal of Haematology|September 7, 2018
Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantationAndrea Jarisch, Emilia Salzmann-Manrique, Holger Cario, et al.
Cytotherapy|November 22, 2015
Challenges in the harmonization of immune monitoring studies and trial design for cell-based therapies in the context of hematopoietic cell transplantation for pediatric cancer patientsStefan Nierkens, Arjan C Lankester, R Maarten Egeler, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in ChildrenSilke Gastine, Thomas Lehrnbecher, Carsten Müller, et al.
Pageof 41